Conclusion Zepbound can affect mental health in different ways
Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study News provided by Acosta Group Apr 14, 2025, 12:05 ET 76% of those who discontinued GLP-1s are eating the same amount or less and many report retaining healthy habits JACKSONVILLE, Fla., April 14, 2025 /PRNewswire/ -- In advance of the National Association of Chain Drug Stores (NACDS) Annual Meeting, Acosta Group is sharing the results of its recent proprietary GLP-1 Shopper Community study, focusing on consumers using the medications specifically to support weight loss
But as with any new medication or weight management method, this class of drugs brings with it many questions
If you are interested in medical weight-loss support, the safest path is to work with a licensed medical provider who can order and review labs, and discuss your health history and goals to determine which evidence-based, legally available weight-loss treatment is the best fit
doi: 10.1016/j.ajog.2019.04.023 7 Thurston RC, Karvonen-Gutierrez CA, Derby CA, El Khoudary SR, Kravitz HM, Manson JE
Additionally, semaglutide acts on appetite centers in the brain, particularly in the hypothalamus, leading to reduced caloric intake and significant weight loss in many patients